State OR
Clinical Trials in Oregon
Recruiting clinical trials with at least one study location in Oregon. Data updated daily from ClinicalTrials.gov.
Top Conditions in Oregon
Malignant Solid Neoplasm (5)Advanced Solid Tumor (5)Prostate Cancer (4)Acute Myeloid Leukemia (4)Parkinson Disease (4)Myeloproliferative Neoplasm (3)Hematopoietic and Lymphatic System Neoplasm (3)Acute Lymphoblastic Leukemia (3)Atopic Dermatitis (3)Breast Cancer (3)Acute Respiratory Distress Syndrome (3)NSCLC (Non-small Cell Lung Cancer) (3)
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT06961370 Phase 1
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodyna...
Condition
Geographic Atrophy
Enrollment
132 pts
Location
United States
Sponsor
Hoffmann-La Roche
NCT06863129 N/A
Recruiting
Proximal FEmur Reconstruction or Internal Fixation fOR Metastases (PERFORM) Tria...
Condition
Metastatic Bone Disease
Enrollment
334 pts
Location
United States, Belgium, Brazil
Sponsor
Michelle Ghert, MD
NCT07106762 Phase 2, Phase 3
Recruiting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Me...
Condition
Urothelial Cancer
Enrollment
470 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT04038502 Phase 2
Recruiting
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Condition
Metastatic Castrate Resistant Prostate Cancer
Enrollment
100 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT05826457 N/A
Recruiting
North American Prodromal Synucleinopathy Consortium Stage 2
Condition
REM Sleep Behavior Disorder
Enrollment
500 pts
Location
United States, Canada
Sponsor
Washington University School o
NCT05112601 Phase 2
Recruiting
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System...
Condition
Endometrial Adenocarcinoma
Enrollment
81 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06664619 Phase 3
Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of F...
Condition
Asthma
Enrollment
724 pts
Location
United States, Argentina, Bulgaria
Sponsor
Teva Branded Pharmaceutical Pr
NCT06560866 N/A
Recruiting
Disrupting SRFOH to Improve Substance Use and Mental Health Outcomes for Parents...
Condition
Substance-Related Disorders
Enrollment
266 pts
Location
United States
Sponsor
Chestnut Health Systems
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT05304767 Phase 3
Recruiting
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive Kar...
Condition
Schizophrenia
Enrollment
280 pts
Location
United States, Bulgaria, Czechia
Sponsor
Karuna Therapeutics, Inc., a B
NCT06036095 Phase 4
Recruiting
Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study
Condition
Neurocognitive Disorders
Enrollment
260 pts
Location
United States
Sponsor
Oregon Health and Science Univ
NCT04485559 Phase 1
Recruiting
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients Wi...
Condition
Recurrent World Health Organization (WHO) Grade II Glioma
Enrollment
50 pts
Location
United States
Sponsor
University of California, San
NCT03779854 Phase 2
Recruiting
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Child...
Condition
Acute Biphenotypic Leukemia
Enrollment
68 pts
Location
United States
Sponsor
Fred Hutchinson Cancer Center
NCT06414954 Phase 2
Recruiting
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia...
Condition
Myasthenia Gravis
Enrollment
84 pts
Location
United States, Belgium, Denmark
Sponsor
NMD Pharma A/S
NCT06253871 Phase 1
Recruiting
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Condition
HER2 Mutation-Related Tumors
Enrollment
243 pts
Location
United States, France, Ireland
Sponsor
Iambic Therapeutics, Inc
NCT06321302 Phase 2
Recruiting
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diab...
Condition
Diabetic Retinopathy
Enrollment
178 pts
Location
United States, Germany, Hungary
Sponsor
Boehringer Ingelheim
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT04775537 N/A
Recruiting
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
Condition
Spinal Disease
Enrollment
120 pts
Location
United States
Sponsor
Collagen Matrix
NCT07195695 Phase 3
Recruiting
Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically...
Condition
Non-small Cell Lung Cancer
Enrollment
400 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT00843375 N/A
Recruiting
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers ...
Condition
Colonic Neoplasms
Enrollment
1,200 pts
Location
United States, Australia, Canada
Sponsor
University of Michigan Rogel C
NCT06673095 N/A
Recruiting
Narrow Excision Versus Wide Excision for the Treatment of Adults With Invasive C...
Condition
Clinical Stage IA Cutaneous Melanoma AJCC v8
Enrollment
1,000 pts
Location
United States
Sponsor
OHSU Knight Cancer Institute
NCT05633667 Phase 2
Recruiting
Study of Novel Treatment Combinations in Patients With Lung Cancer
Condition
Lung Cancer
Enrollment
270 pts
Location
United States, Brazil, Hong Kong
Sponsor
Gilead Sciences
NCT06971731 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phen...
Condition
Phenylketonuria
Enrollment
120 pts
Location
United States, Australia, France
Sponsor
Otsuka Pharmaceutical Developm
NCT04284436 N/A
Recruiting
Study in Parkinson Disease of Exercise
Condition
Parkinson Disease
Enrollment
370 pts
Location
United States, Canada
Sponsor
Northwestern University